IN2012MU00206A - - Google Patents

Download PDF

Info

Publication number
IN2012MU00206A
IN2012MU00206A IN206MU2012A IN2012MU00206A IN 2012MU00206 A IN2012MU00206 A IN 2012MU00206A IN 206MU2012 A IN206MU2012 A IN 206MU2012A IN 2012MU00206 A IN2012MU00206 A IN 2012MU00206A
Authority
IN
India
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN206MU2012 priority Critical patent/IN2012MU00206A/en
Priority to US13/745,010 priority patent/US9283270B2/en
Publication of IN2012MU00206A publication Critical patent/IN2012MU00206A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IN206MU2012 2012-01-20 2012-01-20 IN2012MU00206A (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN206MU2012 IN2012MU00206A (enExample) 2012-01-20 2012-01-20
US13/745,010 US9283270B2 (en) 2012-01-20 2013-01-18 Method for stabilization of biological molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN206MU2012 IN2012MU00206A (enExample) 2012-01-20 2012-01-20

Publications (1)

Publication Number Publication Date
IN2012MU00206A true IN2012MU00206A (enExample) 2013-08-09

Family

ID=48945734

Family Applications (1)

Application Number Title Priority Date Filing Date
IN206MU2012 IN2012MU00206A (enExample) 2012-01-20 2012-01-20

Country Status (2)

Country Link
US (1) US9283270B2 (enExample)
IN (1) IN2012MU00206A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2922569B1 (en) 2012-11-21 2018-01-03 Serum Institute of India Private Limited Production of high yields of bacterial polysaccharides
EP3283102A4 (en) * 2015-04-16 2018-10-03 Inventprise, LLC. Bordetella pertussis immunogenic vaccine compositions
EP3307307A4 (en) 2015-06-09 2019-05-01 The Board of Regents of the University of Oklahoma COMPOSITIONS AND TREATMENTS FOR HAEMOPHILUS INFLUENZAE
EP3344276B1 (en) 2015-09-03 2020-04-22 The Board of Regents of the University of Oklahoma Peptide inhibitors of clostridium difficile tcdb toxin
AU2017321863B2 (en) 2016-09-02 2024-07-11 Sanofi Vaccines US Inc. Neisseria meningitidis vaccine
WO2019050818A1 (en) * 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. METHODS OF FORMULATING PNEUMOCOCCAL POLYSACCHARIDES FOR CONJUGATION TO A CARRIER PROTEIN
US11400162B2 (en) * 2017-02-24 2022-08-02 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
CN107828360A (zh) * 2017-11-16 2018-03-23 西安长峰机电研究所 一种常温固化固体火箭发动机喷管结构粘接剂
EP3781192A1 (en) * 2018-04-16 2021-02-24 Merck Patent GmbH Additives for protein formulations to improve thermal stability
JOP20200214A1 (ar) * 2019-09-03 2021-03-03 Serum Institute Of India Pvt Ltd تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها
NL2023863B1 (en) * 2019-09-20 2021-05-25 Univ Griffith Protein particles and uses thereof
WO2022035816A1 (en) 2020-08-10 2022-02-17 Inventprise, Llc Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
EP4705330A1 (en) 2023-05-05 2026-03-11 The Board of Regents of the University of Oklahoma Variants of adrenomedullin (am) and adrenomedullin 2/intermedin (am2/imd) and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2113348T3 (es) 1989-08-15 1998-05-01 Massachusetts Inst Technology Composiciones de vacunas estabilizadas.
CA2177060A1 (en) 1993-12-21 1995-06-29 Philip J. Provost Thermostable varicella zoster virus
WO1998028000A1 (en) 1996-12-20 1998-07-02 Merck & Co., Inc. Stabilizers for lyophilized vaccines
CN1053590C (zh) 1998-10-19 2000-06-21 卫生部长春生物制品研究所 冻干甲型肝炎减毒活疫苗及其保护剂
ES2307553T3 (es) 1999-12-02 2008-12-01 Novartis Vaccines And Diagnostics, Inc. Composiciones y procedimientos para estabilizar moleculas biologicas tras liofilizacion.
ES2555786T3 (es) * 2007-06-04 2016-01-08 Glaxosmithkline Biologicals Sa Formulación de vacunas contra la meningitis
BRPI0818545A2 (pt) * 2007-10-19 2017-07-04 Novartis Ag formulações de vacinais meningocócicas
BRPI0800357A2 (pt) 2008-03-10 2009-10-27 Fundacao Oswaldo Cruz método para produção de uma vacina estabilizada
AU2011288203A1 (en) * 2010-03-18 2012-08-23 Novartis Ag Adjuvanted vaccines for serogroup B meningococcus

Also Published As

Publication number Publication date
US20130209503A1 (en) 2013-08-15
US9283270B2 (en) 2016-03-15

Similar Documents

Publication Publication Date Title
BR122020002986A2 (enExample)
BR112014017635A2 (enExample)
BR112014020069A2 (enExample)
BR112014017614A2 (enExample)
BR112014017625A2 (enExample)
BR112014017592A2 (enExample)
BR112014017607A2 (enExample)
BR112014023589A2 (enExample)
BR112014017638A2 (enExample)
BR112013027865A2 (enExample)
BR112014017609A2 (enExample)
BR112014019239A2 (enExample)
BR112014017634A2 (enExample)
BR112014017588A2 (enExample)
BR112014013184A8 (enExample)
BR112014017618A2 (enExample)
BR112014017627A2 (enExample)
BR112014017623A2 (enExample)
BR112014017630A2 (enExample)
IN2012MU00206A (enExample)
BR112014017621A2 (enExample)
BR112014017631A2 (enExample)
BR112014017622A2 (enExample)
BR112014018670A2 (enExample)
BR112014023585A2 (enExample)